Skip to main content
. 2018 Jun 5;9:488. doi: 10.3389/fphar.2018.00488

Table 6.

Univariate analysis results.

Medication compliance
Low group (n = 29) High group (n = 63) P
n (%) n (%)
Characteristics
     Age (≥65 years) 17 (58.6) 43 (68.3) 0.480
     Sex (female) 6 (20.7) 15 (23.8) 0.796
     Dialysis period (≥median) 14 (48.3) 33 (52.4) 0.823
     Causative disease (kidney disease) 11 (37.9) 35 (55.6) 0.178
EQ-5D
     Utility value (≥standard value) 9 (31.0) 29 (46.0) 0.254
KDQOL-SF
    Kidney disease-specific scale
     Symptoms (≥mean) 15 (51.7) 40 (63.5) 0.361
     Effect of kidney disease (≥mean) 15 (51.7) 34 (54.0) 1.000
     Burden of kidney disease (≥mean) 18 (62.1) 29 (46.0) 0.182
     Work status (≥mean) 7 (24.1) 12 (19.0) 0.589
     Cognitive function (≥mean) 21 (72.4) 52 (82.5) 0.280
     Quality of social interaction (≥mean) 20 (69.0) 46 (73.0) 0.804
     Sleep (≥mean) 11 (37.9) 39 (61.9) 0.043*
    Non-health related QOL scale
     Social support (≥mean) 20 (69.0) 33 (52.4) 0.175
     Dialysis staff encouragement (≥mean) 19 (65.5) 31 (49.2) 0.179
     Patient satisfaction (≥mean) 14 (48.3) 21 (33.3) 0.248
    Summary score
     PCS (≥50) 4 (13.8) 13 (20.6) 0.568
     MCS (≥50) 25 (86.2) 51 (81.0) 1.000
     RCS (≥50) 16 (55.2) 38 (60.3) 0.656
Medication management situation
     Occupation (employed) 17 (58.6) 42 (66.7) 0.489
     Medication storage (medication bag) 8 (27.6) 20 (31.7) 0.809
     Medication storage state (sheet) 18 (62.1) 40 (63.5) 1.000
     Knowledge of effects (Know a certain amount or above) 18 (62.1) 34 (54.0) 0.505
     Knowledge of side effects (Know a certain amount or above) 7 (24.1) 13 (20.6) 0.787
     Number of types of medication (≥7) 23 (79.3) 53 (84.1) 0.567
     Frequency of administration (≥6 times/day) 13 (44.8) 37 (58.7) 0.262
*

P < 0.05. QOL, Quality of life; EQ-5D, EuroQol 5 dimension; PCS, Physical component summary; MCS, Mental component summary; RCS, Role-social component summary.